By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
A pneumatic rigidifying bladder, which is flexible at atmospheric pressure and rigid at negative pressure or when evacuated, is a component of a tissue stabiliser. The rigidifying bladder is attached to tissue that needs to be stabilised, such a broken limb, using a structure like straps with hook-and-eye attachments.
The bladder is drained when it is placed on the tissue, making it stiff and supporting the tissue. In surgical operations like performing coronary artery bypass grafting (CABG) on a warm, beating heart, the tissue stabiliser may be set up for usage. The tissue stabiliser incorporates an attached bladder with several apertures in a cardiac embodiment.
Suction is used to attach the stabiliser to the epicardium of the heart when it is applied at a port of the attaching bladder’s attaching bladder. At a port of the rigidifying bladder, suction may be administered after it is positioned over the heart. The heart can be manoeuvred as needed to complete CABG procedures even when it is stiff.
The Global Tissue stabiliser market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.
Tissue specimens fixed with the PAXgene by QIAgen Tissue FIX Container are transported or stored using PAXgene Tissue STABILIZER (50 ml). Following the fixation of tissue samples using the PAXgene Tissue FIX Container (50 ml), PAXgene Tissue FIX is withdrawn from the container and replaced with PAXgene Tissue STABILIZER.
Currently, the sample’s morphology, proteins, and nucleic acids are stable for up to 7 days at room temperature, or for longer periods at 2-8°C, -20°C, and even -80°C. For histological examinations, stabilised samples might be embedded in paraffin. The efficient subsequent purification of RNA, miRNA, DNA, and/or proteins from the same material is made possible by PAXgene Tissue Kits and supplemental methods.
The latest generation tissue stabiliser from Medtronic exemplifies the company’s steadfast dedication to cardiac surgeons. The Octopus Evolution AS offers an automated pod spread feature that improves visibility at the anastomotic site along with all the same benefits of the Octopus Evolution, including improved stability, flexibility, and a lower profile for endless placement options. With its smaller profile, increased flexibility, and improved stability, the Octopus Evolution stabiliser offers limitless positioning options.
One of the greatest obstacles in OPCAB operations has always been maintaining long-term device stability. Surgeons have repeatedly been required to interrupt their work in order to retighten the devices. In order to secure the stabilizer in place, they had to rotate the retaining screw on the gripper arm with their working hand. The AESCULAP has solved this issue for good.
The AESCULAP FLEXHeart TISSUE STABILIZER’s electro-PNEUMATIC HYBRID system uses compressed air controlled by buttons. As clever as it is simple. A CO2 cartridge injects compressed air into the device when the surgeon presses the button, allowing arm mobility. The arm is held in the desired position and the air escapes when the button is released.
Tissue stabilizers are made with a high field of action for the surgeon and an optimal operating procedure in mind. The vacuum paddles and holding arm can be positioned freely, resulting in this new quality. Additionally, precise work is possible even in challenging circumstances thanks to the increased visibility.The clinic managers benefit from a economical system.
High flexibility is ensured by the holding arm’s freedom of movement. The surgeon can choose the best personal working position thanks to the arm’s ability to be angled up to 90 degrees with complete freedom.The reusable components comprise the CO2 cartridge adapter, the FLEXHeart Adapter and the FLEXHeart clamp for the stabilizer.
Aesculap, a premium solution provider for OPCAB coronary surgery, provides a comprehensive and coherent range of products as a service to users and patients. All of it coordinated and accessible from a single vendor, resulting in a smooth operation and high patient satisfaction due to the high instrument quality.
The sterile pack for single-use components consists of the FLEXHeart Stabilizer, the vacuum hose and the hybrid cable. The AESCULAP FLEXHeart Tissue Stabilizer embodies a coordinated modular system. Sterile and non-sterile parts can be expanded to a functioning overall system. All single-use parts are supplied in a sterile pack. Both the FLEXHeart clamp in the sterile area and the retractor can be simply reused by means of sterile processing. In the non-sterile area, a disinfectant wipe is sufficient for the FLEXHeart Adapter.
